vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Good Times Restaurants Inc. (GTIM). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $32.7M, roughly 1.4× Good Times Restaurants Inc.). Good Times Restaurants Inc. runs the higher net margin — 0.6% vs -19.9%, a 20.5% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -10.0%). Good Times Restaurants Inc. produced more free cash flow last quarter ($1.2M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -0.7%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Good Times is a Golden, Colorado–based fast-food restaurant specializing in premium burgers and frozen custard. As of July 2023, the chain operates 31 locations, down from 38 in 2015.
ABCL vs GTIM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $32.7M |
| Net Profit | $-8.9M | $181.0K |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 0.9% |
| Net Margin | -19.9% | 0.6% |
| Revenue YoY | 788.4% | -10.0% |
| Net Profit YoY | 73.9% | 10.4% |
| EPS (diluted) | $-0.03 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $32.7M | ||
| Q3 25 | $9.0M | $37.0M | ||
| Q2 25 | $17.1M | $34.3M | ||
| Q1 25 | $4.2M | — | ||
| Q4 24 | $5.0M | $36.3M | ||
| Q3 24 | $6.5M | $35.8M | ||
| Q2 24 | $7.3M | $38.0M | ||
| Q1 24 | $10.0M | $35.4M |
| Q4 25 | $-8.9M | $181.0K | ||
| Q3 25 | $-57.1M | $1.5M | ||
| Q2 25 | $-34.7M | $-624.0K | ||
| Q1 25 | $-45.6M | — | ||
| Q4 24 | — | $164.0K | ||
| Q3 24 | $-51.1M | $230.0K | ||
| Q2 24 | $-36.9M | $1.3M | ||
| Q1 24 | $-40.6M | $618.0K |
| Q4 25 | -63.7% | 0.9% | ||
| Q3 25 | -851.8% | 3.3% | ||
| Q2 25 | -290.2% | -1.5% | ||
| Q1 25 | -1479.6% | — | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | -1439.4% | -0.3% | ||
| Q2 24 | -1276.2% | 3.2% | ||
| Q1 24 | -551.5% | 1.8% |
| Q4 25 | -19.9% | 0.6% | ||
| Q3 25 | -637.8% | 4.0% | ||
| Q2 25 | -203.3% | -1.8% | ||
| Q1 25 | -1077.2% | — | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | -785.4% | 0.6% | ||
| Q2 24 | -504.3% | 3.5% | ||
| Q1 24 | -408.0% | 1.7% |
| Q4 25 | $-0.03 | $0.02 | ||
| Q3 25 | $-0.19 | $0.14 | ||
| Q2 25 | $-0.12 | $-0.06 | ||
| Q1 25 | $-0.15 | — | ||
| Q4 24 | — | $0.02 | ||
| Q3 24 | $-0.17 | $0.01 | ||
| Q2 24 | $-0.13 | $0.12 | ||
| Q1 24 | $-0.14 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $33.2M |
| Total Assets | $1.4B | $82.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | — | ||
| Q2 25 | $92.4M | $2.7M | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | $3.0M | ||
| Q3 24 | $126.6M | $3.9M | ||
| Q2 24 | $148.3M | — | ||
| Q1 24 | $123.6M | $4.0M |
| Q4 25 | $966.9M | $33.2M | ||
| Q3 25 | $964.0M | $33.1M | ||
| Q2 25 | $1.0B | $31.6M | ||
| Q1 25 | $1.0B | — | ||
| Q4 24 | $1.1B | $32.4M | ||
| Q3 24 | $1.1B | $32.4M | ||
| Q2 24 | $1.1B | $32.3M | ||
| Q1 24 | $1.1B | $31.6M |
| Q4 25 | $1.4B | $82.5M | ||
| Q3 25 | $1.4B | $85.8M | ||
| Q2 25 | $1.4B | $86.9M | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.4B | $89.5M | ||
| Q3 24 | $1.4B | $87.1M | ||
| Q2 24 | $1.4B | $90.1M | ||
| Q1 24 | $1.5B | $89.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $1.4M |
| Free Cash FlowOCF − Capex | $-44.6M | $1.2M |
| FCF MarginFCF / Revenue | -99.4% | 3.8% |
| Capex IntensityCapex / Revenue | 21.9% | 0.6% |
| Cash ConversionOCF / Net Profit | — | 7.85× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $-72.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $1.4M | ||
| Q3 25 | $-52.6M | $1.3M | ||
| Q2 25 | $-32.4M | $714.0K | ||
| Q1 25 | $-11.6M | — | ||
| Q4 24 | $-108.6M | $-518.0K | ||
| Q3 24 | $-28.9M | $394.0K | ||
| Q2 24 | $-30.0M | $3.2M | ||
| Q1 24 | $-41.7M | $1.8M |
| Q4 25 | $-44.6M | $1.2M | ||
| Q3 25 | $-61.5M | $735.0K | ||
| Q2 25 | $-45.8M | $-105.0K | ||
| Q1 25 | $-22.2M | — | ||
| Q4 24 | $-187.0M | $-1.9M | ||
| Q3 24 | $-47.4M | $-466.0K | ||
| Q2 24 | $-50.1M | $2.0M | ||
| Q1 24 | $-65.8M | $1.2M |
| Q4 25 | -99.4% | 3.8% | ||
| Q3 25 | -687.0% | 2.0% | ||
| Q2 25 | -267.9% | -0.3% | ||
| Q1 25 | -524.0% | — | ||
| Q4 24 | -3702.8% | -5.3% | ||
| Q3 24 | -728.4% | -1.3% | ||
| Q2 24 | -683.8% | 5.3% | ||
| Q1 24 | -661.5% | 3.2% |
| Q4 25 | 21.9% | 0.6% | ||
| Q3 25 | 99.7% | 1.4% | ||
| Q2 25 | 78.2% | 2.4% | ||
| Q1 25 | 251.1% | — | ||
| Q4 24 | 1552.7% | 3.9% | ||
| Q3 24 | 284.6% | 2.4% | ||
| Q2 24 | 274.6% | 3.2% | ||
| Q1 24 | 242.5% | 1.7% |
| Q4 25 | — | 7.85× | ||
| Q3 25 | — | 0.85× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.16× | ||
| Q3 24 | — | 1.71× | ||
| Q2 24 | — | 2.44× | ||
| Q1 24 | — | 2.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
